Will CV Therapeutics MERLIN trial (Ranexa) hit its endpoint, showing it's safe? Will it be effective for ACS?

0 ⤊

Will CV Therapeutics MERLIN trial (Ranexa) hit its endpoint, showing it's safe? Will it be effective for ACS?

The MERLIN trial is over and Ranexa is being analyzed for safety vs placebo and for efficacy for ACS patients. The TIMI Group is conducting this trial.

2007-02-16 05:26:09 · 1 answers · asked by wisdomseeker 1 in Health ➔ Diseases & Conditions ➔ Heart Diseases

1 answers

It's too premature to say anything. However you cannot take risk on ACS protocols. Wait for the complete and approval by FDA.

2007-02-16 07:32:55 · answer #1 · answered by Dr.Qutub 7 · 0⤊ 0⤋